ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.48M | -4.38M | -4.03M | -4.02M | -3.87M |
| Total Depreciation and Amortization | -592.50K | -579.20K | 692.10K | 689.90K | -523.40K |
| Total Amortization of Deferred Charges | 1.34M | 1.31M | -- | -- | 1.28M |
| Total Other Non-Cash Items | 743.70K | 727.10K | 544.80K | 543.00K | 0.00 |
| Change in Net Operating Assets | -327.30K | -320.00K | -- | -- | 604.70K |
| Cash from Operations | -3.32M | -3.24M | -2.79M | -2.78M | -2.51M |
| Capital Expenditure | -23.80K | -23.30K | -- | -- | -19.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -167.90K | -164.20K | -4.30K | -4.30K | 44.20K |
| Cash from Investing | -191.70K | -187.40K | -4.30K | -4.30K | 25.00K |
| Total Debt Issued | 0.00 | 0.00 | 3.84M | 3.84M | 7.98M |
| Total Debt Repaid | -2.57M | -2.57M | -86.50K | -86.50K | -100.00K |
| Issuance of Common Stock | 7.65M | 7.65M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.61M | -1.61M | -725.50K | -725.50K | -951.50K |
| Cash from Financing | 2.47M | 2.41M | 1.99M | 1.98M | 4.44M |
| Foreign Exchange rate Adjustments | -225.80K | -220.70K | -282.90K | -282.00K | -514.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.26M | -1.24M | -1.09M | -1.09M | 1.44M |